These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17128560)

  • 1. Anabolic steroid and gonadotropin releasing hormone analog combined treatment increased pubertal height gain and adult height in two children who entered puberty with short stature.
    Satoh M; Yokoya S
    J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1125-31. PubMed ID: 17128560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment with Gonadotropin-releasing Hormone Analog and Anabolic Steroid Hormone Increased Pubertal Height Gain and Adult Height in Boys with Early Puberty for Height.
    Tanaka T; Naiki Y; Horikawa R
    Clin Pediatr Endocrinol; 2012 Apr; 21(2):35-43. PubMed ID: 23926409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I; Tanaka T; Tanae A; Kagawa J; Hashimoto N; Yoshizawa A; Shizume K
    J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M; Tanaka T; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.
    Balducci R; Toscano V; Mangiantini A; Municchi G; Vaccaro F; Picone S; Di Rito A; Boscherini B
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3596-600. PubMed ID: 8530605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids.
    Dunkel L
    Horm Res Paediatr; 2011; 76 Suppl 3():27-9. PubMed ID: 21912156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M; Momoi T; Yorifuji T; Muroi J; Yamanaka C; Sasaki H; Furusho K
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined GH and LHRH analog treatment in short children.
    Tanaka T; Satoh M; Hibi I
    Endocr J; 1996 Oct; 43 Suppl():S13-7. PubMed ID: 9076337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth promotion by oxandrolone in a girl with short stature and early pubertal development treated with growth hormone and gonadotropin-releasing hormone-analogue. A case study.
    Hermanussen M
    Acta Paediatr; 1995 Oct; 84(10):1207-10. PubMed ID: 8563241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.
    Zucchini S; Scarano E; Baldazzi L; Mazzanti L; Pirazzoli P; Cacciari E
    J Endocrinol Invest; 2005 Mar; 28(3):274-9. PubMed ID: 15952414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty.
    Lee PA; Houk CP
    Treat Endocrinol; 2006; 5(5):287-96. PubMed ID: 17002488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.